University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Andrew Boyle

Andrew Boyle, M.D.

Interventional cardiologist

Dr. Andrew Boyle is a cardiologist who specializes in coronary artery disease at the UCSF Heart and Vascular Center. An interventional cardiologist, he performs cardiac catheterizations, coronary artery angioplasty and stenting as well as percutaneous closure of atrial septal defects (ASD) and patent foramen ovale (PFO). In addition to caring for patients, he studies adult stem cell therapies for heart disease and new imaging methods.

Boyle grew up in Australia, where he earned a medical degree at Monash University. He completed an internship, residency in internal medicine and fellowship in cardiology at St. Vincent's Hospital in Melbourne, Australia. In 2002, he received board certification in internal medicine and cardiology from the Royal Australasian College of Physicians. During his training, Boyle became interested in developing new techniques, particularly stem cell therapies, to prevent and treat heart failure after a heart attack. He also completed a doctorate degree at the University of Melbourne and Columbia University, New York. Subsequently, he completed a fellowship in interventional cardiology at Johns Hopkins University School of Medicine, where he studied stem cell therapeutics.

Clinics

Cardiovascular Care and Prevention Center at Mission Bay
535 Mission Bay Blvd. South
San Francisco, CA 94158
Phone: (415) 353-2873
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Andrew Boyle

Education

Monash University School of Medicine, Australia 1994

Residencies

St. Vincent's Hospital, Australia, Internal Medicine 1998
St. Vincent's Hospital, Australia, Cardiology 2001

Fellowships

Johns Hopkins Hospital, Interventional Cardiology 2006

Selected Research and Publications

  1. Daly MJ, Boyle AJ, Morrison L, Hunter EK. Visual disturbance following cardiac catheterization. J Am Coll Cardiol. 2013 Jan 22; 61(3):e5.
  2. Natal-Hernandez L, Meadows J, Shunk KA, Boyle AJ. Percutaneous retrograde recanalization of a chronic total coronary artery occlusion in a 7 year old. Cardiovasc Revasc Med. 2013 Mar; 14(2):113-7.
  3. Ye J, Boyle AJ, Shih H, Sievers RE, Wang ZE, Gormley M, Yeghiazarians Y. CD45-positive cells are not an essential component in cardiosphere formation. Cell Tissue Res. 2013 Jan; 351(1):201-5.
  4. Whellan DJ, Sarkar S, Koehler J, Small RS, Boyle A, Warman EN, Abraham WT. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics. Am J Cardiol. 2013 Jan 1; 111(1):79-84.
  5. Nazer B, Hayward RM, Boyle AJ. Simultaneous thrombotic culprit lesions in two separate coronary arteries in a patient with ST-elevation myocardial infarction. Eur Heart J. 2012 Oct; 33(20):2622.
  6. Majure DT, Hallaux M, Yeghiazarians Y, Boyle AJ. Topical nitroglycerin and lidocaine locally vasodilate the radial artery without affecting systemic blood pressure: A dose-finding phase I study. J Crit Care. 2012 Oct; 27(5):532.e9-532.e13.
  7. Dehghani H, Boyle AJ. Percutaneous device closure of secundum atrial septal defect in older adults. Am J Cardiovasc Dis. 2012; 2(2):133-42.
  8. Angeli FS, Zhang Y, Sievers R, Jun K, Yim S, Boyle A, Yeghiazarians Y. Injection of human bone marrow and mononuclear cell extract into infarcted mouse hearts results in functional improvement. Open Cardiovasc Med J. 2012; 6:38-43.
  9. Koskenvuo JW, Sievers RE, Zhang Y, Angeli FS, Lee B, Shih H, Ye J, Boyle AJ, Yeghiazarians Y. Fractionation of mouse bone-marrow cells limits functional efficacy in non-reperfused mouse model of acute myocardial infarction. Ann Med. 2012 Dec; 44(8):829-35.
  10. Ye J, Boyle A, Shih H, Sievers RE, Zhang Y, Prasad M, Su H, Zhou Y, Grossman W, Bernstein HS, Yeghiazarians Y. Sca-1+ cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury. PLoS One. 2012; 7(1):e30329.
  11. Wang TY, Masoudi FA, Messenger JC, Shunk KA, Boyle A, Brennan JM, Anderson HV, Anstrom KJ, Dai D, Peterson ED, Douglas PS, Rumsfeld JS. Percutaneous coronary intervention and drug-eluting stent use among patients =85 years of age in the United States. J Am Coll Cardiol. 2012 Jan 10; 59(2):105-12.
  12. Yeghiazarians Y, Gaur M, Zhang Y, Sievers RE, Ritner C, Prasad M, Boyle A, Bernstein HS. Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition. Cytotherapy. 2012 Feb; 14(2):223-31.
  13. Boyle AJ, Yeghiazarians Y, Shih H, Hwang J, Ye J, Sievers R, Zheng D, Palasubramaniam J, Palasubramaniam D, Karschimkus C, Whitbourn R, Jenkins A, Wilson AM. Myocardial production and release of MCP-1 and SDF-1 following myocardial infarction: differences between mice and man. J Transl Med. 2011; 9:150.
  14. Koskenvuo JW, Mirsky R, Zhang Y, Helenius H, Angeli FS, De Marco T, Boyle AJ, Yeghiazarians Y. Evidence of diminished coronary flow in pulmonary hypertension: explaining angina pectoris in this patient group? Clin Physiol Funct Imaging. 2011 Nov; 31(6):477-84.
  15. Mirsky R, Jahn S, Koskenvuo JW, Sievers RE, Yim SM, Ritner C, Bernstein HS, Angeli FS, Boyle AJ, De Marco T, Yeghiazarians Y. Treatment of pulmonary arterial hypertension with circulating angiogenic cells. Am J Physiol Lung Cell Mol Physiol. 2011 Jul; 301(1):L12-9.
  16. Boyle AJ, Shih H, Hwang J, Ye J, Lee B, Zhang Y, Kwon D, Jun K, Zheng D, Sievers R, Angeli F, Yeghiazarians Y, Lee R. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp Gerontol. 2011 Jul; 46(7):549-59.
  17. Shih H, Lee B, Lee RJ, Boyle AJ. The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol. 2011 Jan 4; 57(1):9-17.
  18. Angeli FS, Amabile N, Shapiro M, Mirsky R, Bartlett L, Zhang Y, Virmani R, Chatterjee K, Boyle A, Grossman W, Yeghiazarians Y. Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction. Cardiovasc Drugs Ther. 2010 Dec; 24(5-6):409-20.
  19. Yong CM, Sharma M, Ochoa V, Abnousi F, Roberts J, Bass NM, Niemann CU, Shiboski S, Prasad M, Tavakol M, Ports TA, Gregoratos G, Yeghiazarians Y, Boyle AJ. Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation. Liver Transpl. 2010 Nov; 16(11):1242-8.
  20. Zellner C, Ports TA, Yeghiazarians Y, Boyle AJ. Sterile radial artery granuloma after transradial procedures: a unique and avoidable complication. Catheter Cardiovasc Interv. 2010 Nov 1; 76(5):673-6.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California